See more : Aimflex Berhad (0209.KL) Income Statement Analysis – Financial Results
Complete financial analysis of Jianmin Pharmaceutical Group Co.,Ltd. (600976.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Jianmin Pharmaceutical Group Co.,Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- GMV Minerals Inc. (GMV.V) Income Statement Analysis – Financial Results
- Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHEZF) Income Statement Analysis – Financial Results
- Star Cement Limited (STARCEMENT.BO) Income Statement Analysis – Financial Results
- Parque Arauco S.A. (PARAUCO.SN) Income Statement Analysis – Financial Results
- GS Yuasa Corporation (GYUAF) Income Statement Analysis – Financial Results
Jianmin Pharmaceutical Group Co.,Ltd. (600976.SS)
About Jianmin Pharmaceutical Group Co.,Ltd.
Jianmin Pharmaceutical Group Co.,Ltd. manufactures and sells Chinese medicines in China. It offers pediatric drugs under the Jianmin and Longmu brands. The company also provides OTC, medical, and health products, as well as consultation service. Jianmin Pharmaceutical Group Co.,Ltd. is headquartered in Wuhan, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.21B | 3.64B | 3.28B | 2.46B | 2.24B | 2.16B | 2.71B | 2.36B | 2.28B | 1.75B | 1.99B | 1.54B | 1.41B | 1.57B | 1.53B | 835.35M | 1.04B | 1.29B | 911.09M | 530.23M | 430.08M | 359.00M | 285.51M |
| Cost of Revenue | 2.27B | 2.07B | 1.85B | 1.46B | 1.34B | 1.41B | 1.97B | 1.79B | 1.81B | 1.31B | 1.55B | 1.17B | 1.08B | 1.25B | 1.25B | 623.43M | 844.29M | 1.11B | 710.90M | 289.66M | 225.71M | 158.69M | 139.53M |
| Gross Profit | 1.94B | 1.58B | 1.43B | 998.09M | 894.21M | 753.37M | 745.39M | 569.69M | 474.62M | 443.80M | 443.44M | 367.35M | 334.86M | 319.97M | 285.30M | 211.93M | 191.83M | 183.27M | 200.19M | 240.57M | 204.37M | 200.31M | 145.97M |
| Gross Profit Ratio | 46.05% | 43.27% | 43.49% | 40.64% | 39.94% | 34.85% | 27.49% | 24.10% | 20.81% | 25.31% | 22.26% | 23.86% | 23.70% | 20.35% | 18.60% | 25.37% | 18.51% | 14.19% | 21.97% | 45.37% | 47.52% | 55.80% | 51.13% |
| Research & Development | 69.23M | 73.19M | 52.61M | 37.40M | 41.01M | 25.62M | 24.08M | 17.71M | 16.09M | 14.84M | 13.91M | 12.83M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 42.44M | 31.85M | 28.14M | 23.71M | 30.81M | 41.21M | 38.28M | 40.33M | 41.19M | 31.27M | 88.59M | 77.09M | 59.97M | 67.68M | 70.90M | 65.85M | 53.09M | 57.90M | 62.83M | 60.53M | 54.07M | 50.15M | 35.52M |
| Selling & Marketing | 1.16B | 1.07B | 991.88M | 787.34M | 687.76M | 549.38M | 527.65M | 381.97M | 298.14M | 228.21M | 245.51M | 198.31M | 182.63M | 171.83M | 152.18M | 112.44M | 104.02M | 98.84M | 103.17M | 129.39M | 97.77M | 100.94M | 68.63M |
| SG&A | 1.21B | 1.10B | 1.02B | 811.05M | 718.57M | 590.58M | 565.93M | 422.30M | 339.33M | 259.48M | 334.10M | 275.40M | 242.60M | 239.51M | 223.09M | 178.29M | 157.12M | 156.74M | 166.00M | 189.92M | 151.83M | 151.09M | 104.15M |
| Other Expenses | 85.09M | 71.50M | 103.46M | 88.17M | 82.26M | 98.65M | 116.41K | 11.60M | 13.60M | 4.25M | 1.25M | 1.88M | 2.58M | 7.45M | 6.76M | 7.90M | 981.31K | 7.10M | 5.11M | -187.26K | -3.04M | -1.05M | -1.58M |
| Operating Expenses | 1.36B | 1.25B | 1.18B | 936.62M | 841.84M | 714.85M | 679.26M | 518.37M | 421.28M | 330.90M | 346.48M | 285.87M | 250.98M | 248.34M | 230.69M | 183.69M | 161.70M | 160.85M | 170.43M | 195.71M | 155.71M | 154.87M | 107.21M |
| Cost & Expenses | 3.64B | 3.31B | 3.03B | 2.39B | 2.19B | 2.12B | 2.65B | 2.31B | 2.23B | 1.64B | 1.90B | 1.46B | 1.33B | 1.50B | 1.48B | 807.11M | 1.01B | 1.27B | 881.33M | 485.38M | 381.41M | 313.56M | 246.74M |
| Interest Income | 3.73M | 4.96M | 1.78M | 723.14K | 311.62K | 289.96K | 1.62M | 1.61M | 5.83M | 5.22M | 4.01M | 6.76M | 5.91M | 5.35M | 6.23M | -786.68K | 779.00 | 3.24M | 3.64M | 4.29M | 604.98K | 1.60M | 2.02M |
| Interest Expense | 4.82M | 4.81M | 3.24M | 547.62K | 666.23K | 579.42K | 4.43M | 3.46M | 4.34M | 4.04M | 1.54M | 4.33M | 4.39M | 2.77M | 0.00 | 4.61M | -777.88K | 5.78M | 4.81M | 2.70M | 2.38M | 1.26M | 1.84M |
| Depreciation & Amortization | 40.33M | 54.68M | 50.04M | 30.59M | 25.76M | 24.67M | 20.23M | 17.14M | 14.80M | 14.41M | 13.30M | 13.37M | 15.37M | 15.87M | 17.13M | 15.60M | 15.66M | 17.90M | 17.20M | 12.13M | 10.02M | 128.60K | 200.63K |
| EBITDA | 615.12M | 481.57M | 288.24M | 178.85M | 120.01M | 108.46M | 123.89M | 68.97M | 100.14M | 149.87M | 123.90M | 104.42M | 108.86M | 113.74M | 71.75M | 45.21M | 45.79M | 45.63M | 56.51M | 58.84M | 55.36M | 47.13M | 41.97M |
| EBITDA Ratio | 14.60% | 14.25% | 12.16% | 7.40% | 5.70% | 5.15% | 4.77% | 4.76% | 5.11% | 9.25% | 6.51% | 7.33% | 8.25% | 7.05% | 6.00% | 6.82% | 4.76% | 3.79% | 6.16% | 11.58% | 12.87% | 13.13% | 14.70% |
| Operating Income | 573.86M | 442.17M | 365.24M | 160.81M | 105.03M | 93.90M | 100.34M | 60.32M | 85.53M | 127.41M | 107.96M | 93.65M | 93.41M | 78.75M | 52.84M | 18.18M | 20.19M | 21.97M | 30.95M | 46.85M | 46.06M | 47.00M | 41.77M |
| Operating Income Ratio | 13.62% | 12.14% | 11.14% | 6.55% | 4.69% | 4.34% | 3.70% | 2.55% | 3.75% | 7.27% | 5.42% | 6.08% | 6.61% | 5.01% | 3.45% | 2.18% | 1.95% | 1.70% | 3.40% | 8.84% | 10.71% | 13.09% | 14.63% |
| Total Other Income/Expenses | -2.77M | -4.23M | -4.81M | -3.20M | -5.24M | -5.91M | 116.41K | 10.63M | 13.08M | 4.01M | 1.10M | 1.64M | -4.44M | 9.29M | 6.11M | 6.51M | 981.31K | 2.73M | 3.18M | 1.61M | -3.10M | -1.14M | -1.64M |
| Income Before Tax | 571.09M | 437.94M | 360.93M | 157.61M | 99.79M | 87.98M | 100.46M | 71.30M | 98.60M | 131.42M | 109.06M | 95.29M | 94.27M | 88.04M | 58.95M | 24.63M | 21.17M | 25.24M | 34.13M | 46.56M | 42.96M | 45.86M | 40.13M |
| Income Before Tax Ratio | 13.56% | 12.03% | 11.01% | 6.42% | 4.46% | 4.07% | 3.70% | 3.02% | 4.32% | 7.49% | 5.47% | 6.19% | 6.67% | 5.60% | 3.84% | 2.95% | 2.04% | 1.95% | 3.75% | 8.78% | 9.99% | 12.78% | 14.06% |
| Income Tax Expense | 47.86M | 32.44M | 35.51M | 8.92M | 7.16M | 6.68M | 9.01M | 6.24M | 11.60M | 12.47M | 12.86M | 12.75M | 16.00M | 19.54M | 12.53M | 9.08M | 12.40M | 11.70M | 9.51M | 15.36M | 14.61M | 15.15M | 13.64M |
| Net Income | 521.46M | 408.08M | 305.26M | 147.79M | 91.49M | 81.22M | 90.78M | 64.66M | 85.50M | 115.97M | 95.90M | 82.45M | 78.25M | 71.69M | 48.86M | 15.78M | 8.33M | 11.49M | 20.02M | 28.01M | 24.31M | 24.72M | 21.67M |
| Net Income Ratio | 12.38% | 11.21% | 9.31% | 6.02% | 4.09% | 3.76% | 3.35% | 2.74% | 3.75% | 6.61% | 4.81% | 5.35% | 5.54% | 4.56% | 3.19% | 1.89% | 0.80% | 0.89% | 2.20% | 5.28% | 5.65% | 6.88% | 7.59% |
| EPS | 3.41 | 2.68 | 2.01 | 0.96 | 0.60 | 0.53 | 0.59 | 0.42 | 0.56 | 0.76 | 0.63 | 0.54 | 0.51 | 0.47 | 0.32 | 0.11 | 0.05 | 0.07 | 0.13 | 0.18 | 0.29 | 0.16 | 0.14 |
| EPS Diluted | 3.41 | 2.68 | 2.01 | 0.96 | 0.60 | 0.53 | 0.59 | 0.42 | 0.56 | 0.76 | 0.63 | 0.54 | 0.51 | 0.47 | 0.32 | 0.11 | 0.05 | 0.07 | 0.13 | 0.18 | 0.29 | 0.16 | 0.14 |
| Weighted Avg Shares Out | 152.92M | 152.50M | 151.87M | 153.32M | 153.40M | 153.24M | 153.40M | 153.40M | 152.68M | 152.59M | 152.23M | 152.69M | 153.43M | 152.52M | 152.68M | 150.07M | 166.53M | 156.80M | 156.80M | 156.80M | 156.80M | 156.80M | 156.80M |
| Weighted Avg Shares Out (Dil) | 152.92M | 152.50M | 151.87M | 153.32M | 153.40M | 153.24M | 153.86M | 153.94M | 152.68M | 152.59M | 152.23M | 152.69M | 153.43M | 152.52M | 152.68M | 150.07M | 166.53M | 156.80M | 156.80M | 156.80M | 156.80M | 156.80M | 156.80M |
No news found for: 600976.SS
Source: https://incomestatements.info
Category: Stock Reports